Statins may slightly raise aging eye disease risk
|
Tweet
|
|
Contrary to the expectations of some scientists, cholesterol-lowering ‘statin’ drugs (such as Lipitor or Zocor) do not appear to stave off age-related macular degeneration (AMD) in the eye.
In fact, a review of data from the Cardiovascular Health Study suggests that taking a statin may slightly increase the risk of AMD, investigators at the University of Alabama at Birmingham report.
Macular degeneration is a condition in which there is progressive deterioration of the central area of the retina, resulting in gradual sight loss in the center of the field of vision.
Although several studies have examined the link between Statins and AMD, the results have been mixed—with some showing a benefit while others demonstrate no association or increased risk, Dr. Gerald McGwin, Jr. and his associates note in the Archives of Ophthalmology for January.
As the researchers explain, some have theorized that AMD results from hardening of the arteries, in which case statin drugs should be protective. However, McGwin’s group has previously found that cholesterol levels were actually lower in patients with AMD than in those without, and other groups have suggested that High cholesterol may paradoxically lower the risk of AMD.
To further explore this issue, McGwin and colleagues analyzed data from 2755 subjects age 65 and older who participated in the Cardiovascular Health Study. They all had eye exams, which uncovered AMD in 390 subjects.
The raw figures indicated that statin use had no effect on the prevalence of AMD. However, after accounting for multiple demographic, behavioral and medical factors, the researchers found that Statins increased the likelihood of AMD by 13 percent. Further adjustment for age, gender and race led to “a modest trend” of increased risk, of 40 percent.
Summing up, the investigators say that whether Statins encourage or hinder AMD “is still an issue of current debate,” which can only be decided by large observational studies.
SOURCE: Archives of Ophthalmology, January 2006.
Revision date: July 4, 2011
Last revised: by Amalia K. Gagarina, M.S., R.D.
| RELATED STORIES: | ||
| Comments | [ + Post Your Own ] |
Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.
There are no comments for this entry yet. [ + Comment here + ]
We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.
All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.
- Full Story - - »»»
Best time for a coffee break? There’s an app for that
- Full Story - - »»»
Cellphone Use Linked to Selfish Behavior in UMD Study
- Full Story - - »»»
Optimism about heart risks may be a good thing
- Full Story - - »»»
New guidelines developed for improved DVT diagnosis
- Full Story - - »»»
Teen pregnancy, abortion rates at record low, study says
- Full Story - - »»»
Think you can’t get pregnant? Try again, study says
- Full Story - - »»»

